메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background: Teicoplanin is a glycopeptide antibiotic that is widely used in clinical practice for the treatment of infections caused bydrug-resistant Gram-positive bacteria. The aim of this study was to analyze plasma teicoplanin concentrations to determine the percentageof patients in whom therapeutic concentrations of teicoplanin were achieved in clinical practice. Materials and Methods: The plasma teicoplanin concentrations of hospitalized patients receiving treatment at a teaching hospitalwere retrospectively analyzed. The target level was defined as a plasma teicoplanin concentration of 10 mg/L or greater, since thiswas generally regarded as the lower limit of the optimal concentration range required for the effective treatment of a majority of infections. Results: Patients with sub-optimal (< 10 mg/L) plasma teicoplanin concentrations constituted nearly half of the total study population. The majority of these patients received the recommended loading dose, which were three 400 mg doses administered every12 hours. Sub-group analysis showed a trend that the group receiving loading dose was more likely to reach the optimal teicoplaninconcentration. Conclusions: The data revealed that a significant proportion of patients in clinical practice achieved only sub-optimal teicoplaninconcentrations, which emphasizes the importance of the mandatory use of loading dose and routine therapeutic drugmonitoring. Treatment reassessment and simulation of individual dose regimens may also be necessary to achieve optimal drugconcentrations.

목차

등록된 정보가 없습니다.

참고문헌 (14)

참고문헌 신청

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0